Yes. 3PBiovian is owned by private equity investor Keensight Capital.
3PBiovian is headquartered in Turku, Finland.
3PBiovian is a life science company.
3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. 3PBiovian's service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adenoassociated viruses, cell therapy, and plasmid DNA production. Additionally, 3PBiovian provide fill and finish services for recombinant proteins and viral vectors. 3PBiovian is based in Turku, Finland.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | - | - | - | 2 | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
